EP 1177288 A1 20020206 - TUMOUR-ASSOCIATED ANTIGEN
Title (en)
TUMOUR-ASSOCIATED ANTIGEN
Title (de)
TUMORASSOZIIERTES ANTIGEN
Title (fr)
ANTIGENE SPECIFIQUE DE TUMEURS
Publication
Application
Priority
- DE 19919225 A 19990428
- EP 0003552 W 20000419
Abstract (en)
[origin: DE19919225A1] The invention relates to a tumour-associated antigen, to immunogenic peptides derived therefrom, to DNA molecules that code for said peptides and to the use thereof in the immunotherapy of cancer.
IPC 1-7
C12N 15/12; C07K 14/47; C12N 9/10; A61K 38/08; A61K 38/04; A61K 31/70; A61K 39/00; C07K 16/18
IPC 8 full level
G01N 33/53 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 14/82 (2006.01); C07K 16/32 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/08 (2006.01); G01N 33/566 (2006.01); G01N 33/574 (2006.01)
CPC (source: EP)
A61P 35/00 (2018.01); C07K 14/4748 (2013.01); A61K 39/00 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/53 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DE 19919225 A1 20001116; AR 023794 A1 20020904; AU 4553100 A 20001117; CA 2365278 A1 20001109; CO 5300468 A1 20030731; EP 1177288 A1 20020206; JP 2004500024 A 20040108; MX PA01010740 A 20020604; WO 0066727 A1 20001109; WO 0066727 A9 20020912
DOCDB simple family (application)
DE 19919225 A 19990428; AR P000102035 A 20000428; AU 4553100 A 20000419; CA 2365278 A 20000419; CO 00030397 A 20000427; EP 0003552 W 20000419; EP 00926997 A 20000419; JP 2000615751 A 20000419; MX PA01010740 A 20000419